Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Mitigating the effects of COVID-19 on advocacy networks

Lydia Makaroff • 10 Sep 2022
ESMO 2022
General

Lydia Makaroff, PhD, Fight Bladder Cancer and World Bladder Cancer Patient Coalition, Cambridge, UK, discusses how to mitigate the impact of the pandemic on advocacy networks, including a call for volunteers and the need for financial support. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Lydia Makaroff

0:54
Role of patient advocacy in clinical trial design
Lydia Makaroff • 10 Sep 2022
0:50
The impact of COVD-19 on advocacy networks
Lydia Makaroff • 10 Sep 2022
0:34
The aims of Fight Bladder Cancer and World Bladder Cancer Patient Coalition
Lydia Makaroff • 10 Sep 2022
0:34
The aims of Fight Bladder Cancer and World Bladder Cancer Patient Coalition
Lydia Makaroff • 10 Sep 2022

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals